AwardedPOLGoods
Koncentrat rekombinowanego wieprzowego czynnika krzepnięcia VIII wraz z dostawą do Regionalnych Centrów Krwiodawstwa i Krwiolecznictwa; znak postępowania: ZZP.ZP.411.82.2026
- Published
- Published 12 May 2026
- Deadline
- Closed 27 May 2026
Overview
Narodowe Centrum Krwi procured recombinant porcine factor VIII concentrate for the treatment of patients with acquired congenital hemophilia A, to be delivered to Regional Blood Donation and Treatment Centers across Poland. Takeda Pharma Sp. z o. o. was awarded the contract on 8 June 2026.
Key details
- Country
- POL
- Status
- Awarded
- Category
- Goods
- Procedure
- Open
- Published
- 12 May 2026
- Deadline
- Closed
Medicinal products for the blood and blood-forming organs
Award outcome
- Award date
- 8 June 2026
- Contract period
- — → 30 September 2026
- Takeda Pharma Sp. z o. o.
Contract ending soon? Skim tracks incumbents and flags recompetes early. Book a demo to set up alerts.
Notice history
Every published notice in this contracting process, newest first.
Contract Award Notice
9 July 2026
Contract Notice
20 May 2026
Contract Notice
11 May 2026
Contracting authority
Narodowe Centrum Krwi
Procuring entityWarszawa, POL
Authority website ↗
Get the full picture
AI analysis, bid scoring, and expert strategy for this tender
Skim analyses every tender against your company profile and tells you whether to bid, how to win, and who you are up against.
See which competitors are winning the contracts you're chasing.
15-minute call. We'll pull the win data on your real pipeline and show you what Skim does with it.